rss
Br J Ophthalmol 2005;89:275-279 doi:10.1136/bjo.2004.050401
  • Clinical science
    • Scientific reports

The effects of atorvastatin in experimental autoimmune uveitis

  1. P B Thomas1,
  2. T Albini1,
  3. R K Giri2,
  4. R F See1,
  5. M Evans1,
  6. N A Rao1
  1. 1The A Ray Irvine Ocular Pathology Laboratory, Doheny Eye Institute, and Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
  2. 2The Department of Biochemistry and Molecular Biology, Keck School of Medicine, University of southern California, Los Angeles, CA, USA
  1. Correspondence to: Narsing A Rao Doheny Eye Institute, DVRC 211, 1450 San Pablo Street, Los Angeles CA 90033, USA; nraousc.edu
  • Accepted 3 August 2004

Abstract

Aim: To investigate the effect of atorvastatin (Lipitor), a commonly used drug for dyslipidaemia in experimental autoimmune uveitis (EAU).

Methods: 48 B10-RIII mice were immunised with human interphotoreceptor retinoid binding protein (IRBP) peptide p161–180. They were divided into three groups of 16 each and treated orally once daily for 14 days; group one received phosphate buffered saline (control group), group two received 1 mg/kg of atorvastatin (low dose group), and group three received 10 mg/kg (high dose). On day 14 lymph nodes, spleens, and right eyes were harvested. RNA was extracted from lymph nodes for RNase protection assay (RPA) to determine proinflammatory (IL-1α and IL-1β), Th1 (TNF-α, IL-2, IL-12), and Th2 (IL-4, IL-5, and IL-10) cytokine levels. Protein was extracted from spleens for western blot to detect the expression of phosphorylated signal transducer and activator of transcription (STAT) 4 and STAT6. The severity of inflammation in enucleated eyes was graded by a masked observer. Paired t test was performed for the mean difference in histological scoring between treated groups and the immunised control group.

Results: Surprisingly, atorvastatin did not modulate the immune response. The proinflammatory cytokines, IL-1α and IL-1β, and Th1 cytokines, TNF-α and IL-2, were upregulated equally in control and atorvastatin treated groups. IL-12 and Th2 cytokines were not upregulated in all three groups. Western blot analysis showed high levels of phosphorylated STAT4, but not STAT6 protein in the control and atorvastatin treated groups. Mean differences in histological scoring between treated groups and the immunised control group were not statistically significant.

Conclusions: Atorvastatin treatment had no effect on Th1 and Th2 cytokine transcription. Although histological grading suggested mildly decreased inflammation in the high dose treated group, the equivalence of cytokine expression in all groups suggests that the statins may not modulate IRBP induced uveoretinitis.

Footnotes

  • Supported in part by National Eye Institute grant EY013253 and core grant 3040 from the National Institutes of Health, Bethesda, MD, USA.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.